Form 4 Tracker
Yishan Li

Director, Executive Chairman, 10% Owner · 1 filing · Latest: Aug 6, 2026

BlossomHill Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing